Ipamorelin Protocol: Complete Cycling & Dosing Guide

Overview

Ipamorelin is a synthetic pentapeptide that functions as a selective growth hormone secretagogue (GHS), triggering pulsatile endogenous GH release through ghrelin receptor activation. Unlike exogenous growth hormone, ipamorelin stimulates your body's own GH production, making it favorable for maintaining natural feedback mechanisms and avoiding receptor downregulation at standard doses.

The compound binds to GHS-R1a receptors in the pituitary and hypothalamus, activating intracellular signaling cascades that result in dose-dependent GH secretion. This endogenous GH stimulates IGF-1 production in the liver, which mediates the majority of downstream anabolic, lipolytic, and regenerative effects. Critically, ipamorelin exhibits high selectivity for GH release with minimal impact on cortisol, prolactin, or ACTH at therapeutic doses—a significant advantage over older GH secretagogues.

Administration Route: Subcutaneous injection only
Typical Dosing Window: 200–300 mcg per injection
Frequency Range: 1–3 times daily
Cost Range: $40–$120 monthly
Half-Life: Approximately 2 hours
Time to Peak GH: ~40 minutes post-injection

Standard Protocol

The baseline protocol for ipamorelin follows a simple structure: inject once or twice daily subcutaneously, typically in the abdominal region, and cycle strategically to prevent tachyphylaxis and maintain pituitary responsiveness.

Dosing Structure

Beginner Dose (First 2 Weeks)

• 100 mcg once daily, preferably in the morning
• This allows assessment of tolerance and individual sensitivity
• Observe for flushing, mild headache, or lightheadedness

Standard Dose (Weeks 3+)

• 200 mcg once or twice daily
• Morning injection is conventional; if using twice daily, separate doses by 6–8 hours
• Evening dosing (6–8 PM) is acceptable but may trigger hunger before bed

Higher Dose Option

• 300 mcg once or twice daily
• Reserve for advanced users with demonstrated tolerance
• Monitor for increased water retention and appetite stimulation

Cycle Timing

The most practical cycling approach alternates between "on" and "off" periods to maintain receptor sensitivity:

5 Days On / 2 Days Off Cycling

• Inject Monday through Friday at your target dose
• Rest Saturday and Sunday
• This prevents down-regulation while maintaining consistent GH stimulus
• Repeat indefinitely for sustained use

Alternatively: 6 Weeks On / 1–2 Weeks Off

• Run full dose for 6 consecutive weeks
• Take 1–2 weeks completely off ipamorelin
• Resume at standard dose
• This pattern allows deeper pituitary recovery and prevents tolerance creep

Aggressive 24/7 Protocol (Not Recommended)

• Continuous daily dosing without off days
• Risk of tachyphylaxis increases significantly after 8–12 weeks
• Typically results in diminished GH response by week 10–12
• Only use if cycling is absolutely impractical, and plan a 2–3 week break every 8 weeks

Goal-Specific Protocols

Protocol for Muscle Preservation & Recovery

Duration: 8–12 weeks
Dosing: 200 mcg twice daily (morning and evening)
Cycle: 5 days on / 2 days off, or continuous with 2-week break after 6 weeks

Rationale: Twice-daily dosing maintains more consistent GH stimulus for anabolic signaling. The IGF-1 elevation supports nitrogen retention and satellite cell activation.

Monitoring: Track body composition via scale, circumference measurements, or DEXA scan. Expect preservation of lean mass during caloric restriction more so than frank muscle gain.

Protocol for Fat Loss & Body Composition

Duration: 12–16 weeks
Dosing: 200 mcg once daily (morning preferred)
Cycle: 5 days on / 2 days off

Rationale: Single daily dosing is sufficient to stimulate GH for lipolytic signaling. Morning injection aligns with natural GH pulses and morning cortisol rhythm. Longer cycle duration allows more consistent fat loss signaling.

Caution: Ipamorelin may increase appetite through ghrelin activity; manage caloric intake accordingly. Some research suggests potential for increased fat deposition in specific contexts—diet quality and training intensity remain paramount.

Protocol for Injury Recovery & Joint Health

Duration: 10–14 weeks minimum
Dosing: 300 mcg once or twice daily
Cycle: Continuous (6 weeks on / 2 weeks off) to maximize IGF-1 signaling for tissue repair

Rationale: Higher dosing and continuous administration theoretically optimize IGF-1 levels for collagen synthesis and chondrocyte activity. No human data confirms efficacy, but mechanistic evidence supports this approach.

Expected Timeline: 4–6 weeks before subjective improvement in joint symptoms; 8–12 weeks for measurable structural changes if they occur.

Protocol for Anti-Aging & General Health Optimization

Duration: Indefinite (with cycling breaks)
Dosing: 200 mcg once daily
Cycle: 5 days on / 2 days off, rotating every 6 weeks with 10–14 day breaks

Rationale: Moderate single-daily dosing maintains IGF-1 elevation without excess water retention. Cycling prevents receptor desensitization and allows physiological recovery periods.

Monitoring: Track skin elasticity, recovery speed, energy levels, and general wellness markers subjectively. Objective markers include IGF-1 serum levels (measure every 8–12 weeks) and body composition.

How to Administer Step-by-Step

Preparation

1. Reconstitution (if using lyophilized powder):

   • Use sterile bacteriostatic water (0.9% sodium chloride or similar)
   • Calculate volume needed: 1 mg vial + 1 mL water = 1 mg/mL concentration
   • Draw appropriate volume into syringe and slowly inject into vial
   • Do NOT shake; gently roll vial between palms for 30–60 seconds until fully dissolved
   • Solution should be clear; discard if cloudy or discolored

2. Storage:

   • Keep lyophilized (unreconstituted) powder in cool, dry place; refrigeration not required
   • Reconstituted solution must be refrigerated (2–8°C) after mixing
   • Use reconstituted ipamorelin within 3–4 weeks for optimal stability
   • Mark vial with reconstitution date using permanent marker

Injection Technique

1. Site Selection:

   • Preferred sites: abdominal subcutaneous tissue (2 inches from navel), upper thigh, back of upper arm
   • Rotate injection sites daily to prevent lipohypertrophy
   • Mark a mental map: Monday = right abdomen, Tuesday = left abdomen, Wednesday = right thigh, etc.

2. Preparation:

   • Wash hands thoroughly with soap and water
   • Wipe injection site with alcohol swab; allow to dry (don't blow dry)
   • Remove insulin syringe from package and ensure needle is intact
   • Draw back plunger to desired volume (typically 0.2 mL for 200 mcg at 1 mg/mL concentration)

3. Injection:

   • Pinch skin at injection site between thumb and forefinger
   • Insert needle at 45-degree angle quickly and smoothly
   • Release pinched skin; inject slowly over 2–3 seconds
   • Withdraw needle and apply light pressure with gauze for 5 seconds if any bleeding occurs

4. Post-Injection:

   • Expect mild transient flushing or warmth within 2–5 minutes (normal)
   • Mild headache may appear within 10–20 minutes; typically resolves within 30–60 minutes
   • Remain seated or lie down if lightheadedness occurs on first dose

Cycle Example: Week-by-Week Schedule (8-Week Fat Loss Protocol)

Post-Cycle: Consider 2–4 week complete break before restarting if pursuing sustained cycling.

What to Expect: Timeline of Effects

Hours 0–1 (Immediate)

• Mild facial flushing or warmth (50–70% of users)
• Possible mild transient dizziness on first injection
• Increased heart rate slightly

Hours 1–2

• Mild headache onset (20–40% of users); usually resolves by hour 1.5–2
• Peak GH release occurs around 40 minutes post-injection
• Hunger stimulation begins (more pronounced at higher doses)

Days 1–3

• Subjective lightheadedness may occur on first 2–3 injections (resolves with habituation)
• Increased appetite continues for 2–4 hours post-injection
• Mild water retention possible by day 3

Weeks 1–2

• Baseline tolerance established; side effects diminish
• Subtle increase in morning water retention
• Improved recovery from training observed by end of week 2 (subjective)

Weeks 2–4

• Mild peripheral edema may develop (especially at higher doses or during higher sodium intake)
• Improved sleep quality reported by some users
• Increased appetite remains consistent throughout day

Weeks 4–8

• Measurable body composition changes become apparent on scale or visual inspection
• Sustained improvement in workout recovery and strength maintenance
• Increased hunger continues; manage via caloric intake and meal timing
• Water retention may plateau or resolve if sodium intake controlled

Weeks 8–12

• More obvious fat loss or muscle preservation depending on training and diet
• Potential tolerance development if running continuously without cycling breaks
• Response may diminish if 5-days-on / 2-days-off cycling not maintained

Common Protocol Mistakes

Mistake #1: Continuous Daily Dosing Without Breaks

• Problem: Receptor desensitization occurs by week 8–12; GH response diminishes significantly
• Solution: Implement 5 days on / 2 days off, or 6 weeks on / 2 weeks off cycling from day one

Mistake #2: Dosing Too High Too Soon

• Problem: Excessive water retention, severe appetite stimulation, increased headache frequency
• Solution: Start at 100 mcg for 2 weeks; titrate to 200 mcg; reserve 300 mcg for experienced users after 4+ weeks

Mistake #3: Injecting at Wrong Time of Day

• Problem: Evening injections can trigger late-night hunger; morning injections align with natural GH pulses
• Solution: Inject between 6–9 AM for optimal timing; if using twice daily, separate by 6–8 hours (morning + early evening ideal)

Mistake #4: Poor Injection Technique

• Problem: Intramuscular injection instead of subcutaneous causes different absorption and increased local inflammation
• Solution: Pinch skin, inject at 45-degree angle into fat layer, not muscle; use insulin syringe (smaller needle = easier SC placement)

Mistake #5: Ignoring Appetite Management

• Problem: Ghrelin activity increases hunger; users consume excess calories and negate fat loss goals
• Solution: Plan meals around injection timing; increase protein and fiber to manage satiety; consider appetite suppressant if necessary

Mistake #6: Reconstituting With Wrong Solution

• Problem: Non-sterile water or incorrect osmolarity causes injection site irritation and absorption issues
• Solution: Use only bacteriostatic water or pharmaceutical-grade saline; never use tap water or distilled water alone

Mistake #7: Forgetting to Rotate Injection Sites

• Problem: Repeated injections in same location cause lipohypertrophy, fibrosis, and reduced absorption
• Solution: Maintain a rotation schedule across abdomen, thighs, and arms; vary sites daily

How to Stack with Other Compounds

Ipamorelin + CJC-1295 (Growth Hormone Stimulation Stack)

• Dosing: 200 mcg ipamorelin daily + 100 mcg CJC-1295 once weekly
• Rationale: CJC-1295 (GHRH analog) works synergistically with ipamorelin (ghrelin analog) to maximize GH secretion
• Cycle: 6 weeks on ipamorelin (5 days on/2 days off) + CJC-1295 weekly; 2 weeks off both
• Effect: Substantially increased IGF-1 levels; heightened anabolic and lipolytic response
• Caution: Increased water retention and appetite; monitor blood glucose

Ipamorelin + Testosterone (Anabolic Stack)

• Dosing: 200 mcg ipamorelin twice daily + standard testosterone replacement or cycle dose
• Rationale: Synergistic anabolic effect; ipamorelin enhances IGF-1 while testosterone drives protein synthesis
• Cycle: Run both continuously or on same schedule (5 days on/2 days off)
• Effect: Superior muscle preservation and recovery; increased body composition improvements
• Caution: Elevated cardiovascular strain; monitor lipids and blood pressure

Ipamorelin + Bremelanotide (Recovery & Sexual Health Stack)

• Dosing: 200 mcg ipamorelin daily + 1–2 mg bremelanotide every other day
• Rationale: Ipamorelin supports tissue recovery; bremelanotide addresses GH-induced sexual side effects
• Effect: Sustained recovery benefit without sexual dysfunction
• Note: No human data supports this combination; theoretical basis only

Ipamorelin Standalone (Recommended for Beginners)

• Dosing: 200 mcg once or twice daily
• Rationale: Allows assessment of individual tolerance and response before adding other compounds
• Duration: Minimum 4–6 weeks before stacking to understand baseline effect

Protocol Quick Reference Table